Meenu Chhabra Net Worth

The estimated Net Worth of Meenu Chhabra is at least $2.02 Million dollars as of 20 May 2024. Ms. Chhabra owns over 4,500 units of Proteostasis Therapeutics Inc stock worth over $42,358 and over the last 9 years she sold PTI stock worth over $0. In addition, she makes $1,980,720 as President, Chief Executive Officer, and Director at Proteostasis Therapeutics Inc.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Ms. Chhabra PTI stock SEC Form 4 insiders trading

Meenu has made over 2 trades of the Proteostasis Therapeutics Inc stock since 2017, according to the Form 4 filled with the SEC. Most recently she exercised 4,500 units of PTI stock worth $42,358 on 20 May 2024.

The largest trade she's ever made was buying 40,000 units of Proteostasis Therapeutics Inc stock on 18 December 2017 worth over $200,000. On average, Meenu trades about 3,179 units every 167 days since 2016. As of 20 May 2024 she still owns at least 4,500 units of Proteostasis Therapeutics Inc stock.

You can see the complete history of Ms. Chhabra stock trades at the bottom of the page.

Meenu Chhabra biography

Meenu Chhabra serves as President, Chief Executive Officer, Director of the Company. From August 2007 to May 2014, Ms. Chhabra was President and Chief Executive Officer at Allozyne, Inc., a biopharmaceutical company. From December 2006 to August 2007, she served as Vice President of Business Development and Licensing at the Novartis Pharmaceuticals division of Novartis AG (NYSE: NVS). From July 2003 to November 2006, she served as Chief Business Officer at BioXell SpA, a spin-off from F. Hoffmann-LaRoche Ltd.’s Milan Research Institute (Italy), where she led corporate development and financing activities. Ms. Chhabra has also held management positions with Fresenius Kabi AG, Warner-Lambert Company, LLC, and Bristol-Myers Squibb Company (NYSE: BMY). She obtained her M.B.A. from York University and her B.Sc. from the University of Toronto.

What is the salary of Meenu Chhabra?

As the President, Chief Executive Officer, and Director of Proteostasis Therapeutics Inc, the total compensation of Meenu Chhabra at Proteostasis Therapeutics Inc is $1,980,720. There are no executives at Proteostasis Therapeutics Inc getting paid more.

How old is Meenu Chhabra?

Meenu Chhabra is 47, she's been the President, Chief Executive Officer, and Director of Proteostasis Therapeutics Inc since 2014. There are 8 older and no younger executives at Proteostasis Therapeutics Inc. The oldest executive at Proteostasis Therapeutics Inc is Franklin Berger, 70, who is the Independent Chairman of the Board.

What's Meenu Chhabra's mailing address?

Meenu's mailing address filed with the SEC is 9704 MEDICAL CENTER DRIVE, , ROCKVILLE, MD, 20850.

Insiders trading at Proteostasis Therapeutics Inc

Over the last 9 years, insiders at Proteostasis Therapeutics Inc have traded over $9,140,918 worth of Proteostasis Therapeutics Inc stock and bought 12,301,024 units worth $94,383,855 . The most active insiders traders include M James Barrett, Llc Fmr, and Bioventures Ltd Novartis Ag.... On average, Proteostasis Therapeutics Inc executives and independent directors trade stock every 36 days with the average trade being worth of $3,463,082. The most recent stock trade was executed by Enterprise Associates 12, L... on 26 November 2019, trading 1,283,919 units of PTI stock currently worth $3,222,637.

What does Proteostasis Therapeutics Inc do?

Complete history of Ms. Chhabra stock trades at Macrogenics Inc and Proteostasis Therapeutics Inc

Proteostasis Therapeutics Inc executives and stock owners

Proteostasis Therapeutics Inc executives and other stock owners filed with the SEC include:

• Meenu Chhabra,
  President, Chief Executive Officer, Director
• Marija Zecevic,
  Chief Operating Officer
• Benito Munoz,
  Chief Scientific Officer
• Jeffery Kelly,
  Independent Director
• Emmanuel Dulac,
  Independent Director
• Kimberlee Drapkin,
  Independent Director
• Badrul Chowdhury,
  Independent Director
• David Arkowitz,
  Independent Director
• Geoffrey Gilmartin,
  Chief Medical Officer
• Franklin Berger,
  Independent Chairman of the Board
• Eric Rabinowitz,
  Director
• Co Plc Perrigo Holdings Ltd...,
  
• M James Barrett,
  Director
• Asset Management, Lp Chen B...,
  
• James M. Detore,
  See Remarks
• Llc Fmr,
  
• Brett R Hagen,
  Principal Accounting Officer
• Po Shun Lee,
  See Remarks
• Bioventures Ltd Novartis Ag...,
  
• Enterprise Associates 12, L...,
  
• Eric D Larson,
  See Remarks
• Helen M Boudreau,
  Director
• Enterprise Associates 12, L...,
  
• Sheila Wilson,
  Chief Operating Officer
• Christopher T Phd Walsh,
  Director
• Janet L Smart,
  See Remarks
• Christopher Mirabelli,
  Director
• Romeo Mirzac,
  Principal Accounting Officer
• Christopher Health Care Ven...,
  
• Conor M Walshe,
  Director